Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03178773 · ClinicalTrials.gov registry record · Phase 2
TExT-MED + FANS Full Trial
A Phase 2 study of Diabetes, sponsored by University of Southern California.
- Completed
- Registry status
- Phase 2
- Development phase
- 166
- Enrollment target
- 1
- Study location
NCT03178773 is a Phase 2 study of Diabetes that has completed, run by University of Southern California. The registered enrollment target is 166 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03178773, a Phase 2 study of Diabetes, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 166 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an intervention to study incorporating social support into mHealth interventions for low-income, ED patients with diabetes
Conditions Studied
Interventions
- BEHAVIORAL TExT-MED
- BEHAVIORAL FANS
Study Locations (1)
California
- LAC+USC Medicine Center Emergency Department - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2017-07-18 |
| Est. Completion | 2019-12-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03178773
The ClinicalTrials.gov registry entry for NCT03178773 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 166 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (95% lower). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which TExT-MED is the first listed.
NCT03178773 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03178773 about?
NCT03178773 is a clinical study titled "TExT-MED + FANS Full Trial". This is an intervention to study incorporating social support into mHealth interventions for low-income, ED patients with diabetes
What is the current status of trial NCT03178773?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 166 participants. The study started on 2017-07-18. Estimated completion is 2019-12-02.
What conditions does trial NCT03178773 study?
This clinical trial studies the following conditions: Diabetes.
What interventions are being tested in trial NCT03178773?
The interventions under investigation include: TExT-MED (BEHAVIORAL), FANS (BEHAVIORAL).
Who is sponsoring clinical trial NCT03178773?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03178773 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
-
GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
RECRUITING · Phase 2
-
Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy
ACTIVE NOT RECRUITING · Phase 2
-
Biomarker Guided Therapies in Stage A/B Heart Failure
COMPLETED · Phase 2
-
Health Beliefs, Glycemic Control, and Preventing Cognitive Decline in African Americans with Diabetes and Mild Cognitive Impairment: a Randomized Clinical Trial
COMPLETED · Phase 2
-
Effects of Human Leptin Replacement
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.